Inhibition of GSK-3-beta as a Therapeutic Option to Modulate Oxidative Stress via the WNT/beta-Catenin Pathway in Parkinson’s Disease
Jennifer Oruebor Introduction. Parkinson’s Disease (PD) is a neurodegenerative disorder characterized by motor symptoms including tremor, bradykinesia, and postural imbalance. 1 PD pathology includes loss of dopaminergic neurons in the substantia nigra pars compacta and the deposition of alpha-synuclein protein aggregates (Lewy bodies).1 The loss of dopaminergic neurons in the…